Company Search:
Advanced Search
Sponsored Links
Stada Arzneimittel AG Company Snapshot
Stada Arzneimittel AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Stada Arzneimittel AG with three other pharmaceutical manufacturers in Europe: H. Lundbeck A/S of Denmark (2016 sales of 15.63 billion Danish Kroner [US$2.47 billion] of which 19% was Other Pharmaceuticals), Hikma Pharmaceuticals PLC of the United Kingdom (£1.45 billion [US$1.91 billion] of which 40% was Injectable Pharmaceuticals), and Ipsen SA which is based in France (1.67 billion Euro [US$1.97 billion] of which 76% was Specialty Care).

Sales Analysis. Stada Arzneimittel AG reported sales of 2.14 billion Euro (US$2.52 billion) for the year ending December of 2016. This represents a very small increase of 1.1% versus 2015, when the company's sales were 2.12 billion Euro. Sales at Stada Arzneimittel AG have increased during each of the previous five years (and since 2011, sales have increased a total of 25%). Sales of Generics saw an increase that was more than double the company's growth rate: sales were up 5.2% in 2016, from 1.22 billion Euro to 1.28 billion Euro. Not all segments of Stada Arzneimittel AG experienced an increase in sales in 2016: sales of Group Holding Company/other fell 98.9% to 1,000.00 Euro. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Stada Arzneimittel AG
  Stock Performance Chart for Stada Arzneimittel AG
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): 82.25
(Figures in Euro)
1 Week -0.4%   13 Weeks 3.2%  
4 Weeks 26.2%   52 Weeks 72.6%  
Stada Arzneimittel AG Key Data:
  Ticker: SAZ Country: Germany
  Exchanges: FRA OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 2,139,220,000
(Year Ending Jan 2017).
Employees: 10,923
  Currency: Euro Market Cap: 5,120,670,903
  Fiscal Yr Ends: December Shares Outstanding: 62,257,397
  Share Type: Namensaktie Closely Held Shares: 2,372,945
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.